Old Web
English
Sign In
Acemap
>
Paper
>
Epigenome signature as an immunophenotype indicator prompts durable clinical immunotherapy benefits in lung adenocarcinoma.
Epigenome signature as an immunophenotype indicator prompts durable clinical immunotherapy benefits in lung adenocarcinoma.
2022
Xu Pan
Cai-Yu Zhang
Junwei Wang
Peng Wang
Yue Gao
Shipeng Shang
Shuang Guo
Xin Li
Hui Zhi
Shangwei Ning
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]